These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 21491939

  • 1. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
    Elschenbroich S, Ignatchenko V, Clarke B, Kalloger SE, Boutros PC, Gramolini AO, Shaw P, Jurisica I, Kislinger T.
    J Proteome Res; 2011 May 06; 10(5):2286-99. PubMed ID: 21491939
    [Abstract] [Full Text] [Related]

  • 2. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, St Onge P, Kireeva I, Schmitt-Ulms G, Brown TJ, Murphy J, Rosen B, Shaw P, Jurisica I, Kislinger T.
    J Proteome Res; 2008 Jan 06; 7(1):339-51. PubMed ID: 18076136
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG, Kuk C, Smith CR, Batruch I, Soosaipillai A, Diamandis EP.
    J Proteome Res; 2009 Oct 06; 8(10):4705-13. PubMed ID: 19663500
    [Abstract] [Full Text] [Related]

  • 4. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y, Wu X, Liu X, Yan G, Xu C.
    J Proteome Res; 2010 Dec 03; 9(12):6180-90. PubMed ID: 21028892
    [Abstract] [Full Text] [Related]

  • 5. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF, Kuppusamy R, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Nicolaides K.
    J Proteome Res; 2011 Jan 07; 10(1):133-42. PubMed ID: 20499897
    [Abstract] [Full Text] [Related]

  • 6. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F, Nicole White C, Xiao X, Feng Y, Xu C, He D, Zhang Z, Yu Y.
    Gynecol Oncol; 2006 Feb 07; 100(2):247-53. PubMed ID: 16229881
    [Abstract] [Full Text] [Related]

  • 7. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A, Mazzucchelli GD, De Pauw E.
    Talanta; 2010 Feb 15; 80(4):1487-95. PubMed ID: 20082806
    [Abstract] [Full Text] [Related]

  • 8. Systematic quantification of peptides/proteins in urine using selected reaction monitoring.
    Selevsek N, Matondo M, Sanchez Carbayo M, Aebersold R, Domon B.
    Proteomics; 2011 Mar 15; 11(6):1135-47. PubMed ID: 21360671
    [Abstract] [Full Text] [Related]

  • 9. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics.
    Lebert D, Dupuis A, Garin J, Bruley C, Brun V.
    Methods Mol Biol; 2011 Mar 15; 753():93-115. PubMed ID: 21604118
    [Abstract] [Full Text] [Related]

  • 10. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K, Katagiri T, Shimada T, Irie S, Sato TA, Nakamura Y, Daigo Y.
    J Proteome Res; 2007 Sep 15; 6(9):3475-83. PubMed ID: 17705522
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y, Downing SR, Kim D, Hahn WC, Li C, Kantoff PW, Wei LJ.
    Bioinformatics; 2007 Jun 15; 23(12):1451-8. PubMed ID: 17459967
    [Abstract] [Full Text] [Related]

  • 12. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S, Kislinger T.
    Mol Biosyst; 2011 Feb 15; 7(2):292-303. PubMed ID: 20976349
    [Abstract] [Full Text] [Related]

  • 13. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N, Oliva KT, Barker G, Hoffmann P, Reeve S, Smith IA, Quinn MA, Rice GE.
    Proteomics; 2005 Nov 15; 5(17):4625-36. PubMed ID: 16220531
    [Abstract] [Full Text] [Related]

  • 14. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):3-11. PubMed ID: 17023222
    [Abstract] [Full Text] [Related]

  • 15. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH, Pan S, Zhang J, Gao J.
    Rapid Commun Mass Spectrom; 2010 Feb 15; 24(4):403-8. PubMed ID: 20069694
    [Abstract] [Full Text] [Related]

  • 16. Use of stable isotope dimethyl labeling coupled to selected reaction monitoring to enhance throughput by multiplexing relative quantitation of targeted proteins.
    Aye TT, Low TY, Bjørlykke Y, Barsnes H, Heck AJ, Berven FS.
    Anal Chem; 2012 Jun 05; 84(11):4999-5006. PubMed ID: 22548487
    [Abstract] [Full Text] [Related]

  • 17. Selected reaction monitoring applied to proteomics.
    Gallien S, Duriez E, Domon B.
    J Mass Spectrom; 2011 Mar 05; 46(3):298-312. PubMed ID: 21394846
    [Abstract] [Full Text] [Related]

  • 18. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A, Jurisica I, Kislinger T.
    Expert Rev Proteomics; 2008 Aug 05; 5(4):551-60. PubMed ID: 18761466
    [Abstract] [Full Text] [Related]

  • 19. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Roberts CT, Nagalla SR.
    J Proteome Res; 2009 Jan 05; 8(1):239-45. PubMed ID: 19118452
    [Abstract] [Full Text] [Related]

  • 20. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.
    Paweletz CP, Wiener MC, Bondarenko AY, Yates NA, Song Q, Liaw A, Lee AY, Hunt BT, Henle ES, Meng F, Sleph HF, Holahan M, Sankaranarayanan S, Simon AJ, Settlage RE, Sachs JR, Shearman M, Sachs AB, Cook JJ, Hendrickson RC.
    J Proteome Res; 2010 Mar 05; 9(3):1392-401. PubMed ID: 20095649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.